Cytogenetics in the management of hematological malignancies: An overview of alternative technologies for cytogenetic characterization.
Genomic characterization is an essential part of the clinical management of hematological malignancies for diagnostic, prognostic and therapeutic purposes. Although CBA and FISH are still the gold standard in hematology for the...
Read More